Which medication is commonly used for treatment of joint pain in SLE?

Nonsteroidal anti-inflammatory drugs (NSAIDs) are commonly employed to manage joint pain in systemic lupus erythematosus (SLE). SLE is an autoimmune disorder characterized by a variety of symptoms, including musculoskeletal manifestations such as arthritis and joint pain. NSAIDs work by reducing inflammation and alleviating pain, making them a first-line treatment option for managing these symptoms in individuals with SLE.

In addition to NSAIDs, there are other treatments available for SLE. Oral glucocorticoids may be used for more severe symptoms or flares but are typically reserved for cases where NSAIDs are insufficient. Hydroxychloroquine is an antimalarial drug that can help manage systemic symptoms of SLE and also has some efficacy in treating arthritis associated with the disease; however, it is not the primary treatment for joint pain. Anticaridolipin IgG is an antibody associated with the antiphospholipid syndrome and is more relevant for assessing risk of thrombosis rather than a direct treatment for pain.

Thus, NSAIDs are frequently the first choice for effectively alleviating joint pain associated with SLE, which underscores their importance in the management of this condition.